A non-invasive brain pulse oximeter that continuously measures oxygen levels to detect early signs of hypoxia following traumatic brain injury.

An in-trial oral insulin to improve the lives of people with Type 1 diabetes and their health experience.

A long-term, compact device that functions like a real heart and can be transplanted to replace a patient’s failing one.

Developing an innovative adjunctive peptide therapy to reduce the amount of insulin needed for better glucose monitoring in managing Type 1 diabetes.

Allows tracking and sharing of vital sign data with clinicians via Bluetooth monitor to enable remote post-discharge cardiac rehabilitation.

A viral delivery system that transports a protein to enable pancreatic cells to regulate insulin production and consequently, glycemia levels.

An online psycho-educational program to reduce hypoglycaemia-related anxiety and improve mental health outcomes in patients with Type 1 Diabetes.

A drug with the potential to reduce the build-up of plaque in arteries via targeting a receptor involved in the body’s inflammation response.

An innovative app that aims to provide peer support, mental health support and clinical care to young Australians with diabetes.